Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey S Freed

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
American Journal of Surgery|August 30, 2008
Relevant recertification-a problem for specialty boardsJeffrey S Freed
Journal of the American College of Surgeons|February 19, 2021
Gasless Laparoscopy: A Double-Edged Sword in the Developing WorldJeffrey S Freed, Philip Landrigan
Military Medicine|April 11, 2018
An Innovative Advance in Non-invasive Wound Closure: A New ParadigmJeffrey S Freed, John Ko
Case Reports in Emergency Medicine|July 14, 2021
A Recent Advance in the Closure of Skin Wounds on Fragile SkinJohn Ko, Jeffrey S Freed
Personalized Medicine|May 23, 2018
Healthcare's ascension to patient-centered genomic careSteven Ar Murphy, Jeffrey S Freed
Case Reports in Gastroenterology|June 9, 2012
Protein-losing enteropathy in ulcerative colitisRyan Ungaro, Mark W Babyatsky, Hongfa Zhu, et al.
Psychopharmacology|February 27, 2004
Antidepressant-like effects of a novel pentapeptide, nemifitide, in an animal model of depressionDavid H Overstreet, Joseph Hlavka, John P Feighner, et al.
Annals of Global Health|June 2, 2020
Which Country is Truly Developed? COVID-19 has Answered the QuestionJeffrey S Freed, Soo Y Kwon, Hannah Jacobs El, et al.
International Clinical Psychopharmacology|December 20, 2007
Clinical effect of nemifitide, a novel pentapeptide antidepressant, in the treatment of severely depressed refractory patientsJohn P Feighner, Lev Sverdlov, Joseph Hlavka, et al.
The International Journal of Neuropsychopharmacology|September 17, 2003
Clinical effectiveness of nemifitide, a novel pentapeptide antidepressant, in depressed outpatients: comparison of follow-up re-treatment with initial treatmentJohn P Feighner, Lev Sverdlov, Gabriela Nicolau, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
American Journal of Surgery|August 30, 2008
Relevant recertification-a problem for specialty boardsJeffrey S Freed
Journal of the American College of Surgeons|February 19, 2021
Gasless Laparoscopy: A Double-Edged Sword in the Developing WorldJeffrey S Freed, Philip Landrigan
Military Medicine|April 11, 2018
An Innovative Advance in Non-invasive Wound Closure: A New ParadigmJeffrey S Freed, John Ko
Case Reports in Emergency Medicine|July 14, 2021
A Recent Advance in the Closure of Skin Wounds on Fragile SkinJohn Ko, Jeffrey S Freed
Personalized Medicine|May 23, 2018
Healthcare's ascension to patient-centered genomic careSteven Ar Murphy, Jeffrey S Freed
Case Reports in Gastroenterology|June 9, 2012
Protein-losing enteropathy in ulcerative colitisRyan Ungaro, Mark W Babyatsky, Hongfa Zhu, et al.
Psychopharmacology|February 27, 2004
Antidepressant-like effects of a novel pentapeptide, nemifitide, in an animal model of depressionDavid H Overstreet, Joseph Hlavka, John P Feighner, et al.
Annals of Global Health|June 2, 2020
Which Country is Truly Developed? COVID-19 has Answered the QuestionJeffrey S Freed, Soo Y Kwon, Hannah Jacobs El, et al.
International Clinical Psychopharmacology|December 20, 2007
Clinical effect of nemifitide, a novel pentapeptide antidepressant, in the treatment of severely depressed refractory patientsJohn P Feighner, Lev Sverdlov, Joseph Hlavka, et al.
The International Journal of Neuropsychopharmacology|September 17, 2003
Clinical effectiveness of nemifitide, a novel pentapeptide antidepressant, in depressed outpatients: comparison of follow-up re-treatment with initial treatmentJohn P Feighner, Lev Sverdlov, Gabriela Nicolau, et al.
Pageof 1